Blockbuster Drugs Not Worth the Effort?

From About.com:

"The pharmaceutical industry has been widely criticized for many years now for not investing enough in innovation and producing too many 'me-too' drugs that are derivatives of existing drugs.

McKinsey has just published a report concluding that 'Pharmaceutical companies that make massive investments to discover revolutionary blockbuster drugs would probably see better returns by enhancing existing compounds.'"